What is ledipasvir 90 mg/sofosbuvir 400 mg used for?

Ledipasvir/sofosbuvir, sold under the trade name Harvoni among others, is a medication used to treat hepatitis C. It is a combination of ledipasvir and sofosbuvir. Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype 1. Some evidence also supports use in HCV genotype 3 and 4. It is taken daily by mouth for 8–24 weeks. Cure rates are 94% to 99% in people infected with genotype 1. It has also been evaluated for the treatment of infection with other hepatitis C genotypes, and has shown promising results in genotypes 3 and 4.
Most studies indicate that the efficacy rate is between 94% and 97%; much higher than previous treatment options. That treatments could be conducted at very low costs was demonstrated by Hill and coworkers who presented data on 1,160 patients who used generic versions of solfosbuvir, ledipasvir, plus daclatasvir from suppliers in India, Egypt, China and other countries and reported over 90% success.
Source Content : wikipedia

Drug procurement of ledipasvir/sofosbuvir brands in India, sold by Indian Drug Manufacturer. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
ledipasvir 90 mg/sofosbuvir 400 mg

Get In Touch

Ledipasvir/Sofosbuvir suppliers & wholesalers in India

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA.
For Indian Patients Hepcinat-LP Tablets can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India.
For overseas patient Hepcinat-LP brands in India can be also made available to overseas patients, doctors and hospitals. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

Ledipasvir/Sofosbuvir Biosimilar Medicine approved and marketed in India is available as ledipasvir 90 mg/sofosbuvir 400 mg tablets.